We propose to develop general and robust HTS methods that enable the discovery of small molecules that switch, for example, disease states to healthy states without requiring knowledge of the relevant cellular target(s) in advance of the screen. These methods require the ability to perform multiple measurements per well that together define signatures of the relevant states. Small-molecule, high-throughput screens often entail a single measurement per well, for example, the activity of a singular, purified enzyme. In principle and in practice, the ability to perform multiple measurements per well provides novel scientific insights, as demonstrated through high-content expression- and image-based screening. To illustrate: 1) cells treated with small molecules have been probed with Luminex beads to determine the relative amounts of RNAs (mRNA, miRNA)13'43, 2) multiple cellular features have been measured and selected as state classifiers using image-analysis software developed by researchers at the Broad Institute38'39, and 3) protein microarray and Luminex bead-based methods have been adapted to the analyses of phosphoproteins in cells65'66. Such capabilities underlie signature-based state-switching screens, which permit the probing of biological and disease circuitries in order to discover small molecules able to switch one state to the other. (Methods for making multiple measurements can also permit extremely efficient screens where each of the individual measurements is of particular, but not necessarily related, importance, e.g., where the many RNAs being measured each represent a singular biological or therapeutic probe.)

National Institute of Health (NIH)
National Human Genome Research Institute (NHGRI)
Specialized Center--Cooperative Agreements (U54)
Project #
Application #
Study Section
Special Emphasis Panel (ZRG1-IFCN-K)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Broad Institute, Inc.
United States
Zip Code
Bekendam, Roelof H; Bendapudi, Pavan K; Lin, Lin et al. (2016) A substrate-driven allosteric switch that enhances PDI catalytic activity. Nat Commun 7:12579
Lewis, Timothy A; Sykes, David B; Law, Jason M et al. (2016) Development of ML390: A Human DHODH Inhibitor That Induces Differentiation in Acute Myeloid Leukemia. ACS Med Chem Lett 7:1112-1117
de Waal, Luc; Lewis, Timothy A; Rees, Matthew G et al. (2016) Identification of cancer-cytotoxic modulators of PDE3A by predictive chemogenomics. Nat Chem Biol 12:102-8
Bageshwar, Umesh K; VerPlank, Lynn; Baker, Dwight et al. (2016) High Throughput Screen for Escherichia coli Twin Arginine Translocation (Tat) Inhibitors. PLoS One 11:e0149659
Zielonka, Jacek; Zielonka, Monika; VerPlank, Lynn et al. (2016) Mitigation of NADPH Oxidase 2 Activity as a Strategy to Inhibit Peroxynitrite Formation. J Biol Chem 291:7029-44
Sykes, David B; Kfoury, Youmna S; Mercier, François E et al. (2016) Inhibition of Dihydroorotate Dehydrogenase Overcomes Differentiation Blockade in Acute Myeloid Leukemia. Cell 167:171-186.e15
Dockendorff, Chris; Faloon, Patrick W; Pu, Jun et al. (2015) Benzo-fused lactams from a diversity-oriented synthesis (DOS) library as inhibitors of scavenger receptor BI (SR-BI)-mediated lipid uptake. Bioorg Med Chem Lett 25:2100-5
Lukens, Amanda K; Heidebrecht Jr, Richard W; Mulrooney, Carol et al. (2015) Diversity-oriented synthesis probe targets Plasmodium falciparum cytochrome b ubiquinone reduction site and synergizes with oxidation site inhibitors. J Infect Dis 211:1097-103
Park, Sae Woong; Casalena, Dominick E; Wilson, Daniel J et al. (2015) Target-based identification of whole-cell active inhibitors of biotin biosynthesis in Mycobacterium tuberculosis. Chem Biol 22:76-86
Dockendorff, Chris; Faloon, Patrick W; Germain, Andrew et al. (2015) Discovery of bisamide-heterocycles as inhibitors of scavenger receptor BI (SR-BI)-mediated lipid uptake. Bioorg Med Chem Lett 25:2594-8

Showing the most recent 10 out of 39 publications